Health Care For All, Still

Abby Zimet

With the fate of President Obama's proposed $634 billion set aside for healthcare reform still unresolved, the pharmaceutical industry is busy leveraging a place in the budget debate. PhRMA president Billy Tauzin says greater access to health care is all well and good, but oversight of the effectiveness of treatments and other reforms must not interfere with "the wonderful, uniquely American experience in which doctors and patients make their decisions about health care" – a wonderful experience that millions of uninsured currently don't share. 

To see more about what the drug lobby thinks of reform go here. To urge Congress to ignore them and keep healthcare reform on the table, go here

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Share This Article

More in: